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Abstract: Pseudomonas aeruginosa is the prototypical biofilm-forming gram-negative opportunistic
human pathogen. P. aeruginosa is causatively associated with nosocomial infections and with
cystic fibrosis. Antibiotic resistance in some strains adds to the inherent difficulties that result
from biofilm formation when treating P. aeruginosa infections. Transcriptional profiling studies
suggest widespread changes in the proteome during quorum sensing and biofilm development.
Many of the proteins found to be upregulated during these processes are poorly characterized
from a functional standpoint. Here, we report the solution NMR structure of PA1324, a protein of
unknown function identified in these studies, and provide a putative biological functional
assignment based on the observed prealbumin-like fold and FAST-NMR ligand screening studies.
PA1324 is postulated to be involved in the binding and transport of sugars or polysaccharides
associated with the peptidoglycan matrix during biofilm formation.
Keywords: Pseudomonas aeruginosa PA1324; NMR; functional genomics; NMR high-throughput
screens; protein-ligand binding; protein-ligand co-structures; structural biology; structural
genomics; chemical proteomics; protein structure initiative; hypothetical proteins; FAST-NMR;
Northeast Structural Genomics Consortium
Introduction
Genome sequencing projects conducted in the past dec-
ade have enabled many novel areas of research in biol-
ogy, chemistry, and drug discovery. With more than
686 completed genomes and 1270 on-going projects,
6.5 million protein sequences have been identified, but
30–50% of these proteins are not functionally anno-
tated.1 The protein structure initiative (PSI) was initiated
to determine a representative structure for each protein
in the proteome with an expectation that structural in-
formation will assist in solving the functional annotation
problem.2 PSI protein selection is based on the goal of
maximizing the coverage of structural space by choosing
representative targets from protein families that lack a
known structure.3 A single structure may serve as a
model for the other member in the protein family.4
Since 2004, PSI has been shown to contribute
50% of the novel structures deposited in the protein
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database (PDB).5 This coincides with an increase in the
number of proteins classified as unknown function,
where there are currently 2755 such proteins in the
PDB.6 A number of computational methods have been
developed to aid in the annotation of proteins of
unknown function.7 These methods use protein struc-
tures and a range of techniques to compare global folds,
local structural features, or matches to 3D templates to
assign putative biological functions.8 Although these
computational approaches are extremely efficient in ana-
lyzing large data sets, the results for a specific protein
may be ambiguous or absent.9,10
Functional Annotation Screening Technology by
NMR (FAST-NMR) provides experimental data for the
functional annotation of novel proteins by combining
ligand affinity screens and structural biology with bio-
informatics.7,11 Functional ligands that bind to the pro-
tein are identified using a tiered NMR ligand screen.12
The protein’s functional epitope is determined by map-
ping the ligand induced chemical shift perturbations
(CSPs) onto the surface of the protein. A co-structure
is rapidly determined using this CSPs data,13 which is
then used to drive the bioinformatics analysis. The
Comparison of Protein Active Site Structures (CPASS)
program and database compares the experimental
ligand-defined active site determined from the FAST-
NMR screen to all the ligand-defined active sites avail-
able in the PDB.7,11,14 A general biological function is
assigned through the comparative similarity of the
experimentally determined ligand binding site with a
protein of known function.
The sequence of the Pseudomonas aeruginosa
PA01 genome was completed in 2000, but as of January
2008 > 43% of the proteome lacks a functional annota-
tion.15 P. aeruginosa is one of the primary bacteria that
forms biofilms16,17 and causes serious problems with
individuals with chronic lung problems, such as cystic
fibrosis.17,18 In the past decade, the prevalence of noso-
comial infections has risen significantly, particularly in
developing countries.19,20 Biofilms are often the cause of
these infections, and their formation is poorly under-
stood.21 This situation is further exacerbated by the
increasing rate of antibiotic resistance for P. aeruginosa,
which has reached upwards of 40% for some strains.
Resistance to imipenem, ciprofloxacin, and ceftazidine
have all been observed in the past year.22 Therefore,
developing new antibiotics against P. aeruginosa bio-
films is of great importance, requiring the identification
of new drug targets.23,24
P. aeruginosa genes that are upregulated in bio-
films may represent potential therapeutic targets.
PA1324 is an example of such a gene that was identi-
fied by microarray analysis of gene expression associ-
ated with biofilms and quorum sensing in P. aerugi-
nosa. PA1324 and PA1323 were identified in two
expression profiling studies in association with quo-
rum sensing: transcription of both genes appears to
increase similarly in quorum sensing conditions.25,26
One of these studies indicated that PA1324 and
PA1323 expression was not repressed upon treatment
of cells with furanone, a repressor of quorum sens-
ing.25 A study of biofilm formatation found PA1324 to
be significantly upregulated with expression levels 10–
30 times higher versus planktonic cultures.27 PA1323
was upregulated as well. Another study of biofilm for-
mation in P. aeruginosa included microarray data
indicating that PA1324 is not regulated by the SadARS
three-component regulatory system required for bio-
film maturation.28 To better understand the role of
PA1324 in biofilms, the structure and putative biologi-




PA1324 (21–170) is target PaP1 of the Northeast Struc-
tural Genomics Consortium (NESG; www.nesg.org)29,30
and is currently listed as a hypothetical protein in
KEGG31 and TIGR.32 PA1324 occurs in at least five
strains of P. aeruginosa and has several homologues
from a diverse assortment of proteobacteria, all with 26–
28% sequence identity (Fig. 1). The proteins identified in
the BLASTp sequence analysis as being most similar to
PA1324 are hypothetical proteins and putative lipopro-
teins. Residues 1–18 in PA1324 are predicted to be
a hydrophobic signal peptide by SOSUI.33 Thus,
PA1324 was expressed with a 20 residue His-tag
(GSSHHHHHHSSGLVPRGSHM) in place of the signal
peptide plus two residues at the N-terminus, such that
the numbering of residues 21–170 corresponds to the
natural PA1324 sequence.
The gene for PA1323 is in the same reading frame
as PA1324 and terminates just 60 base pairs upstream
from the start of PA1324, suggesting the two genes
may form an operon. PA1323 is a conserved hypotheti-
cal protein (COG4575, Pfam05957, DUF883). On the
same strand and upstream from PA1323 is the gene
for PA1322, which is a putative TonB-dependent re-
ceptor-like transporter for catechols/ferric iron uptake
(FIU). Interestingly, Psi-BLAST queries with the
PA1324 sequence report low similarity hits with E
scores of >0.2 to the N-terminal region of numerous
TonB-dependent receptor-like proteins (though not
any of the FIU class). The N-terminal 150–200 amino
acids of many TonB receptors form a plug on the peri-
plasmic side of the membrane that helps control trans-
port through the barrel-like receptor-transporter. This
may suggest a role for PA1324 and PA1323 in media-
ting the activity of PA1322; however, in the absence of
structural information, the sequence similarity may be
too low to be reliable.
PA1324 structure description and analysis
The solution structure of the globular portion (residues
21–170) of protein PA1324 from P. aeruginosa was
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determined by NMR. Table I summarizes key details
of the structural ensemble. PA1324 forms an elongated
barrel-like sandwich of two b-sheets, open on one side
of the sandwich, and partially closed on the other, but
not to the extent that the edge strands form hydrogen
bonds to each other (Fig. 2). Around the barrel the
strands occur in the order 7-1-4-3-2-5-6. A prominent
loop of 37 residues between strands 2 and 3 (from res-
idue 71 to 107) folds back upon the outside of the bar-
rel and appears to form a pocket. Several polar resi-
dues occupy this pocket: E134, R91, G84, T153, Y79,
S132, E70, R104. Near the N-terminal purification tag
(residues 1–20), residues 27 to 41 form a loose region
that contacts (NOEs observed) the prominent loop,
but does not form a regular structure that is converged
in the ensemble. The fold of the barrel-like sandwich
is clearly that of the prealbumin-like fold (SCOP),
which contains several superfamilies, including that of
the thyroxine transport protein transthyretin (pre-al-
bumin) and of a conserved accessory domain of mem-
brane-type carboxypeptidases. One subfamily of the
transthyretin superfamily is a starch-binding domain,
and recent evidence from the Gene Ontology database
suggests that PA1324 has a carbohydrate-binding
domain.38
Dali analysis of PA1324 revealed several proteins
of modest structural similarity, with Z-scores of
between 2 and 5.39 Despite sequence similarities less
than 20%, these proteins clearly adopt the same fold
as PA1324. The top protein identified was transthyre-
tin. Other proteins identified have functions corre-
sponding to sugar and polysaccharide-binding pro-
teins, extracellular matrix and cell adhesion proteins
and structural proteins. Because the Dali and primary
sequence analysis were unsuccessful for definitive
functional annotation, further investigation was
needed to uncover a putative biological function of
PA1324.
FAST-NMR results for PA1324
FAST-NMR was used to screen ligands for possible
binding by PA1324 to leverage a functional hypothesis.11
FAST-NMR provides functional information for hypo-
thetical proteins by experimentally identifying ligands
and ligand binding sites. After ligands are identified and
the binding site is mapped by CSPs, a co-structure is
obtained in 30–45 min by using the CSPs to direct an
AutoDock simulation where our ADF program selects
the best conformer based on consistency with the magni-
tude of chemical shift changes.13 A functional hypothesis
can be developed by comparing the ligand-defined
active-site from FAST-NMR to a database of protein-
ligand binding sites for proteins of known function using
CPASS (Comparison of Protein Active-Site Struc-
tures).7,11,14 This information provides a starting point
for further functional investigations, additional screen-
ing of related ligands, ligand modification or optimiza-
tion, or even identification of drug leads.
FAST-NMR consists of a two-stage screening
methodology. The primary 1D 1H line-broadening
screen yielded 20 hits from the functional compound
library (5.46% hit rate) that bind PA1324.12 Figure 3
shows a representative example of the typical results
obtained from these line broadening experiments,
where the increase of line width (decrease in peak in-
tensity) indicates a binding event. Seven of these 20
compounds contain aryl-sulfonate, sulfonyl fluoride, or
sulfone functional groups. This suggests potential
chemical characteristics that may be present in the
native ligand. Some of the compounds found to bind
Figure 1. Multiple sequence alignment of PA1324 and six homologues. Gene names and NCBI RefSeq numbers are
indicated by three letter abbreviations as follows: Pae, Pseudomonas aeruginosa PA1324, NP_250015; Csa,
Chromohalobacter salexigens Csal_0658, YP_572718; Sde, Saccharophagus degradans Sde_0431, YP_525907; Dvu,
Desulfovibrio vulgaris Dvul_1060, YP_966507; She, Shewanella sp. W3-18-1 Sputw3181_2461, YP_963839; Sul, Sulfurovum
sp. NBC37-1 SUN_1567, YP_001358874.
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PA1324 in the 1D 1H line-broadening screen are shown
in Figure 4.
The 20 compounds were further evaluated for
PA1324 binding with a secondary screen using the 2D
1H-15N HSQC experiment. CSPs were identified
through the comparison of a reference 2D 1H-15N
HSQC spectrum for free PA1324 to the spectrum in the
presence of the compound. Suramin was identified as
the primary lead compound based on the larger quan-
tity and greater magnitude of CSPs observed relative to
the other compounds [Fig. 5(A)]. Suramin is a known
analogue of heparin, a highly negatively charged sul-
fated biopolymer from the glycosaminoglycan family of
carbohydrates.41 Titration of suramin into a sample of
PA1324 was conducted to determine the suramin bind-
ing site. 2D 1H-15N HSQC spectrum of the PA1324-sur-
main complex showed the backbone amide chemical
shifts of residues N23, T38, L52, M76, K77, G84, L86,
D101, Y130, T153, K154, and S159 were perturbed upon
the addition of suramin. Interestingly, this putative
suramin binding site resembles a heparin binding site
because it contains regions of positively charged lysine
and arginine residues.42,43 Figure 5(B) shows an elec-
trostatic potential surface of the binding site of





Medium range (1 < |ij| < 5) 189
Long range 617






Restricting restraints per restrained residue (144 residues) 11.8
Restricting restraints, long range, per restrained residue (144 residues) 4.7
Average restraint violations per structure
Distance restraints (all > 0.0 Å) 60.1  5.1
Maximum violation (Å) 0.05
Dihedral restraints (all > 0.00) 6.3  3.8
Maximum violation () 1.02
RMSD to average structures (Å):
Residues 27–170 (144 residues)
Backbone atoms (N,C,C0) 0.92
All heavy atoms 1.42
Residues 42–70, 108–170 (92 residues)a
Backbone atoms (N,C,C0) 0.66
All heavy atoms 1.08
Residues 33–37, 43–57, 60–82, 86–113, 116–140, 144–159, 161–168b
Backbone atoms 0.80
All heavy atoms 1.20
Ramachandran plotc:
Protein residues 27–170 inclusive (144) Barrel only (92) Ordered (120)
Most favored region (%) 84.0 86.6 89.6
Additional allowed region (%) 14.3 12.6 10.3
Generously allowed region (%) 1.4 0.2 0.1
Unallowed region (%) 0.3 0.4 0.0
Global quality scoresd: Raw Z-Score
PROCHECK(all) 0.46 2.72
PROCHECK(phi-psi) 0.60 2.05






a b-barrel residues only.
b Mean pairwise RMSD for the 120 ordered residues determined by PSVS.34
c Calculated with PROCHECK.35
d Calculated for the ordered residues.
e Calculated with MolProbity.34,36
f Calculated with AutoStructure.37
Mercier et al. PROTEIN SCIENCE VOL 18:606—618 609
Figure 2. Structure of PA1324 21-170. Left: ribbon cartoon structure with rainbow coloring. The N- (blue) and C- (red) termini,
the prominent loop (residues 71–107), and b-strands of the barrel (numbered 1–7) are indicated. Right: stereo view of
backbone atoms for all 20 superimposed structures comprising the ensemble.
Figure 3. A 1D 1H NMR line-broadening experiment showing an expanded reference mixture spectrum (A) and the mixture
with PA1324 (B). The highlighted region indicates the observed line broadening and binding of suramin to PA1324.
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suramin. A titration with a heterogeneous sample of
heparin (Sigma Aldrich, St. Louis, MO) was also com-
pleted [Fig. 1(S)]. Heparin appears to bind predomi-
nately in the same cleft occupied by suramin.
Possible structures of PA1324 bound to suramin
were modeled using the NMR-defined binding site to
guide an AutoDock simulation.13 Figure 5(C) shows a
co-structure of suramin in the FAST-NMR defined
PA1324 binding site, which was compared with all
other ligand-defined binding sites in the PDB using
CPASS. The highest CPASS scoring comparisons
(40–45% similarity) were from proteins involved in
polysaccharide biosynthesis, the cellulosome (scav-
enger of plant cell-wall polysaccharides), transport,
and DNA binding proteins (segregation proteins).
Many of these proteins bind sugars and polysaccha-
rides. A comparison of the FAST-NMR defined
PA1324 binding site to the protein with the highest
CPASS score, the spore coat polysaccharide biosynthe-
sis protein SpsA from Bacillus subtilis (PDB ID 1H7L)
bound to thymidine-50-phosphate (TMP),44 shows
many similar features and interactions (Fig. 6). SpsA
Figure 4. A subset of the 20 compounds found to bind to PA1324 by 1D 1H NMR line-broadening experiments was Aryl or
benzyl sulfonyl, and sulfonate moieties are present in 7 of the 20 compounds.
Figure 5. Suramin binding to PA1324. (A) An expanded region of an overlay of the 2D 1H-15N HSQC spectrum of free
PA1324 (black) and PA1324 in the presence of suramin (red). (B) A GRASP40 electrostatic surface of PA1324 demonstrating
the positive electrostatic potential of the suramin binding site. Blue and red indicate positively charged and negatively
charged surfaces, respectively. (C) A docked model of suramin in the PA1324 binding site identified by
FAST-NMR. Residues that incurred a CSP upon binding suramin are colored blue. The distal CSPs could be long-range
effects of the binding interaction or potential suramin conformational exchange.
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is a glycosyltransferase, but although the PA1324 has a
similar binding site to SpsA, the functional analysis by
FAST-NMR does not indicate any enzymatic activity
for PA1324. The 1D 1H NMR spectrum of suramin in
the presence of PA1324 does not undergo any changes
with time. The CPASS results do, however, support the
DALI inference relating the putative biological func-
tion of PA1324 with general sugar binding proteins
and transport.
Discussion
Functional analysis of PA1324
Chronic pulmonary infection with P. aeruginosa is the
major cause of mortality among cystic fibrosis
patients.45 P. aeruginosa virulence results from its an-
tibiotic resistance and the ability of P. aeruginosa to
form biofilms. PA1324 was identified as being signifi-
cantly upregulated in P. aeruginosa biofilms along
with PA1323.46 P. aeruginosa biofilms are controlled
by known quorum-sensing systems47–49 that coordi-
nate the regulation of gene transcription through the
secretion of signaling molecules or autoinducers.50 The
transcription of genes for both PA1323 and PA1324
have been demonstrated to increase similarly under
quorum sensing conditions,25,51 but are not affected by
furanone, a repressor of quorum sensing.25 A number
of environmental factors have also been shown to
induce biofilm formation,52,53 which includes anaero-
bic conditions,54 Fe limitation,55–57 high osmolarity,58
and high temperature.58 Interestingly, sub-inhibitory
concentrations of some antibiotics were found to
enhance biofilm formations.59 The addition of etha-
nol,60 oleic acid,61 glucose,62 and UDP-N-acetylglucos-
amine63 also stimulate biofilms.
An important component of biofilm formation is
the production of an extracellular polysaccharide
called polysaccharide intercellular adhesin (PIA) that
mediates cell–cell adhesion.64 Bacteria within a bio-
film are embedded in this hydrated extracellular ma-
trix composed of b (1-6)-linked N-acetylglucosamine
polymer.65,66 Glucose is required for PIA production,67
where UDP-N-acetylglucosamine is the precursor of
the biofilm’s polysaccharide matrix.63 The addition of
both glucose and UDP-N-acetylglucosamine stimulate
PIA production and biofilm formation.62,63 Interest-
ingly, N-acetylglucosamine is also a repeating unit
within heparin, which also has been shown to stimu-
late biofilm formation.68 Furthermore, heparin plays
an important role in P. aeruginosa adherence to epi-
thelial respiratory cells through an interaction with
P. aeruginosa outer-membrane proteins.69
The tertiary structure of PA1324 determined by
NMR indicates a barrel-like sandwich topology corre-
sponding to a prealbumin fold. This fold contains a
carbohydrate-binding superfamily, where the highest
similarity from a Dali analysis identified a protein
involved in transport. Other low-similarity proteins
from the Dali analysis include sugar or heparin bind-
ing proteins and proteins involved in the extracellular
matrix or cell adhesion. Recent evidence from the
Gene Ontology database also suggests PA1324 is a car-
bohydrate-binding domain.38 The FAST-NMR screen
found only one significant compound that bound to
PA1324—suramin, a heparin analog. The suramin
PA1324 binding site was compared with all ligand
binding sites in the PDB using CPASS, where the high-
est CPASS scores were to proteins that interact with
carbohydrates or carbohydrate-like molecules. Site-
directed mutational studies for a number of carbohy-
drate binding domains (CBD) indicate some common
features for carbohydrate affinity. Specifically, carbo-
hydrate binding involves a combination of hydrogen-
bond and aromatic interactions, where replacing
Figure 6. The CPASS comparison of PA1324 with suramin (left) to 1H7L, a spore coat polysaccharide biosynthesis protein
bound to thymidine-50-phosphate (right). The sequence alignment below the figures illustrates the similarities in the ligand
binding sites.
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conserved hydrogen bonding (D, N, E, Q, K, R) or aro-
matic residues (W, Y) significantly diminished or elim-
inated carbohydrate binding.70–72 These specific amino
acid interactions have been corroborated by NMR and
x-ray structures of CBD bound to carbohydrates.73–75
Importantly, the experimentally identified PA1324 sur-
amin binding site contains these typical carbohydrate
binding residues (D, N, K, Y). The ability of PA1324 to
bind carbohydrates was further confirmed by the ob-
servation that PA1324 binds heparin in a manner simi-
lar to suramin.
The binding affinity of carbohydrates to CDBs
tend to range from low micromolar to 100s of micro-
molar, where the magnitude of the dissociation con-
stant (KD) is strongly dependent on the carbohy-
drate.71–78 For example, the affinity of cyanovirin-N to
Man-2 and Man-9 were determined to be 757  80
lM and 3.4  0.05 lM, respectively.78 Similarly, the
human and mouse galectin-9 N-terminal carbohydrate
recognition domains were shown to bind 42 different
carbohydrates with KDs ranging from 0.3 lM to 109
lM.75 The PA1324 NMR chemical shift titration stud-
ies provides a KD estimate of 152  18 lM and 51 
14 lM for suramin and heparin, respectively. This is
consistent with other CBDs, especially considering that
suramin is an unoptimized structural homolog of the
natural ligand and heparin is a heterogeneous mixture.
The gene for PA1322, a putative TonB-dependent
receptor-like transporter,79 is on the same strand and
upstream from PA1323 and PA1324. P. aeruginosa
TonB1 was shown to be essential in both biofilm for-
mation and quorum sensing.80 This activity is separate
from its known role in iron uptake. Furthermore, a
TonB-dependent receptor was identified that trans-
ports sucrose in the phytopathogenic bacterium Xan-
thomonas campestris pv. campestris and is conserved
in other bacteria.81 Similarly, a TonB-dependent recep-
tor that transport maltodextrins across the outer mem-
brane were identified in Caulobacter crescentus.82
These observations suggest that TonB-dependent
receptors transport other nutrients besides iron and
vitamin B12 and may play a role in PIA production.
83
This is especially relevant because heparin and UDP-
N-acetylglucosamine stimulate PIA production and
biofilm formation, where UDP-N-acetylglucosamine is
also a PIA precursor.
The genetic organization of TonB-dependent
receptors implies that functionally related proteins
(r and anti-r) are neighboring genes,79 which infers
an association between PA1322, PA1323, and PA1324.
PA1323 is predicted by Phobius84 to contain at least
one transmembrane helix and exhibits sequence simi-
larity to other putative membrane proteins. The TonB
dependent regulatory systems consist of a number of
membrane bound proteins (anti-r, TonB, ExbB,
ExbD) suggesting a potential biological role for
PA1323. PA1324 has a predicted signal peptide sug-
gesting transport to the membrane. Also, PA1324 has
shown low-sequence similarity (E scores of >0.2) to
the N-terminal region of TonB-dependent receptor-like
proteins, which forms a plug that controls substrate
transport through the barrel-like receptor-transporter.
Deleting the plug domain inactivates substrate trans-
port where activity is regenerated by cosynthesis of the
separate plug and b-barrel domains.85 The plug struc-
ture consists of a twisted b-sheet with loops and heli-
ces connecting the strands, where the substrate binds
the outer surface of the plug.86 Interestingly, an iso-
lated plug domain does not adopt a folded structure.87
Although there appears to be some gross similarities
between the PA1324 NMR structure and the general
description of a plug domain, Dali did not predict any
similarity between the two structures. Also, a sequence
alignment of PA1322 with other known TonB-depend-
ent receptor proteins implies an intact N-terminus in
PA1322. Thus, does PA1324 represent an alternative
mechanism of regulating PA1322, the putative TonB-
dependent receptor-like transporter by mimicking a
folded plug domain complexed to a substrate?
Combining the sequence and structural analysis
with the functional screening, we suggest a role for
PA1324 in carbohydrate binding or transport together
with PA1323, the protein predicted to co-express with
PA1324. PA1324 and PA1323 might be involved in the
polysaccharide secretion or scavenging process
required for PIA formation in P. aeruginosa biofilms.
This biological function may also involve the regula-
tion of PA1322, a putative TonB-dependent receptor-
like protein that may transport carbohydrates across
the P. aeruginosa membrane.
Materials and Methods
Sample preparation
Chemicals were purchased from Sigma (St. Louis,
MO). Stable isotope-labeled compounds were pur-
chased from Cambridge Isotope Laboratories (Ando-
ver, MA). Genomic DNA from P. aeruginosa strain
PA01 was obtained from the American Type Culture
Collection (Manassas, VA). Primers were designed for
PCR amplification of the PA1324 21-170 gene frag-
ment, so that residues 1–20 (MLSIKKNLGLLAMTAA-
LAAC) would be absent in the expressed protein. Resi-
dues 1–18 are predicted to be a hydrophobic signal
peptide by SOSUI.33 Thus, the 170 residue expressed
protein is PA1324 21–170 with a 20 residue His-tag
(GSSHHHHHHSSGLVPRGSHM) in place of the signal
peptide sequence at the N-terminus. A M21A mutation
occurs as a cloning artifact at the insertion point in
the expression vector, pET28b. Escherichia coli
[Rosetta BL21(DE3)] cells were transformed by heat
shock with this vector and plated on LB agar plates
containing 30 lg/mL kanamycin. Single colonies from
the plate were used to inoculate 4 mL overnight seed
cultures in M9 minimal medium made with U-15N
NH4Cl (1 g/L) and U-
13C glucose (2 g/L) and
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supplemented with 7.5 lM FeCl3, 10 lM ZnSO4, and
10 lM MnSO4; seed cultures were shaken overnight at
37C, then used to inoculate 50 mL starter cultures;
these were grown to OD600 0.7 and diluted into 0.5 L
media in 2L glass flasks. When the cultures reached
OD600 0.6–0.8, expression of PA1324 was induced
with 1.1 mM IPTG, the flasks were moved to a 25C
shaking incubator for overnight growth. After 15 h,
cells were pelleted with gentle centrifugation and
resuspended in 25 mL lysis buffer (50 mM sodium
phosphate, 500 mM NaCl, 10 mM imidazole, pH 8.0).
Cells were lysed by passage four times through a
French Press. After insoluble material was removed by
centrifugation, protamine sulfate (12.5 mg) was added
to precipitate nucleic acids, and the supernatant was
ultracentrifuged for 1 h. The His-tagged protein was
loaded onto a gravity column containing 10 mL Ni-
NTA affinity resin (Qiagen, Valencia, CA) equilibrated
with lysis buffer, washed with 50 mL lysis buffer, and
removed with elution buffer (50 mM phosphate, 500
mM NaCl, 400 mM imidazole). Protein in elution
buffer was exchanged into NMR buffer (20 mM BisT-
ris Propane, 300 mM NaCl pH 6.8) on a PD10 col-
umn. The yield of protein was >100 mg/L of culture.
For NMR samples, 7% (v/v) D2O was added, and 250
lL of sample was put into a Shigemi NMR tube. In
addition, a U-15N and 5% biosynthetically directed
fractionally 13C-labeled sample was generated for ster-
eospecific assignment of isopropyl methyl groups in
leucine and valine residues by growing cells as
described above but with 5% of the carbon as U-13C-
glucose and 95% as unenriched glucose.88
NMR structure determination
NMR experiments were conducted at 298 K using
standard triple-resonance experiments.89,90 NMR
experiments were conducted at the Environmental
Molecular Sciences Laboratory of Pacific Northwest
National Laboratory, Richland, WA. Experiments were
collected on Varian Inova 600, 750, and 800 instru-
ments. The following experiments were recorded:
1H-15N-HSQC, 1H-13C-HSQC, HNCO, HNCA,
HNCOCA, HNCACB, CBCACONNH, CBCACOCAHA,
CCC-TOCSY-NNH, HCC-TOCSY-NNH, HCCH-TOCSY,
HCCH-COSY, 3D-15N-NOESY (100 ms mixing time),
4D-13C-13C-HMQC-NOESY-HMQC (80 ms mixing
time), two 3D-13C-NOESYs (80 ms mixing time) opti-
mized for either aliphatic or aromatic carbons, HNHA,
and aromatic ring side chain correlation experiments
(HBCBCG-CDHD/-CEHE). All pulse sequences were
from the BioPack library (Varian) except 4D-13C-13C-
HMQC-NOESY-HMQC, and HBCBCG-CDHD/-CEHE-
aro, which were from Lewis Kay (University of
Toronto). Amide proton exchange was monitored by
acquiring 1H-15N-HSQC spectra following dissolution
of lyophilized protein in D2O. Stereospecific Leu and
Val side chain assignments were obtained from a
1H-13C-HSQC experiment recorded on the 5% 13C-sam-
ple.88 Chemical shift assignments were deposited to
BioMagResBank (bmrb-id 6343).
NOESY peak assignments and preliminary struc-
ture ensembles were determined with AutoStructure
using peak-picked NOESY data and chemical shift
assignments as input.37 Manual inspection of the data
clearly indicated the correct fold was calculated, and
manual refinement of the preliminary ensemble and
error-checking of the restraint lists was conducted
using XPLOR-NIH, using standard sa.inp and dgsa.inp
protocols modified to use 20,000 high temperature
steps at 2000 K, followed by 200,000 cooling steps (3
fs steps). Sum averaging of NOE restraints was used.
Final refinement in explicit water solvent models with
Lennard-Jones and electrostatic potentials included
was accomplished with CNS using a modification of
the procedure and forcefield of Nilges.91 NOE distance
restraints had uniform lower bounds of 1.8 Å and
upper bounds of either 2.8, 3.0, 3.5, 4.0, 4.5, or 5.0 Å.
Hydrogen bond restraints were derived from amide
proton D2O exchange data. Amide
1H-15N-HSQC cross
peaks still present 30 min. after dissolution of a lyoph-
ilized sample in D2O were given bounds of 1.8–2.5 Å
for the HN-O distance and 2.8–3.5 Å for the N-O
distance, provided preliminary structural ensembles
clearly indicated the probable acceptor atom. Dihedral
restraints were obtained from TALOS,92 only those
dihedrals with a score of 10 were used. TALOS
reported restraints were given bounds of  30 for phi
and  40 for psi, and only dihedral angles in regions
of regular secondary structure except in regions where
the angle reported by TALOS was consistent with the
HNHA experiment for phi angles or with the ratio of
sequential interresidue and intraresidue amide NH to
CaH cross peak intensities in the 15N NOESY data.93
The entire ensemble of 20 structures calculated, to-
gether with the distance and dihedral restraints, was
deposited to the Protein Data Bank (pdb-id 1XPN).
FAST-NMR
The 1D 1H NMR line-broadening samples consist of
100 lM of each compound and 25 lM protein in a 20
mM D-Bis-Tris buffer with 11.1 lM TMSP as a NMR
reference in 100% D2O at pH 7.0 (uncorrected). The
NMR spectra were collected on a Bruker 500 MHz
Avance spectrometer equipped with a triple-resonance,
Z-axis gradient cryoprobe, a BACS-120 sample
changer, and Icon NMR software for automated data
collection. 1H NMR spectra were collected with 128
transients at 298 K with solvent presaturation of the
residual HDO, a sweep-width of 6009 Hz and 32 K
data points and a total acquisition time of 6 min. The
NMR spectra were processed automatically using a
macro in the ACD/1D NMR manager (Advanced
Chemistry Development, Toronto, ON). The NMR data
was Fourier transformed, zero-filled, phased, and
baseline corrected. Each spectrum was referenced with
the TMSP peak set to 0.0 ppm and peak-picked.
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Compounds were identified as binding by a visual
comparison of the free and protein spectra for all 113
mixtures.
Only the 20 compounds that exhibited line broad-
ening in the 1D 1H experiment were used in the 2D
1H-15N HSQC experiments to verify specific binding
and identify the ligand binding site. Twenty-one 2D
1H-15N HSQC spectra were collected with 16 transients
at 298 K with a sweep-width of 6009 Hz and 1 K data
points in the direct dimension and 1612 Hz and 256
data points in the indirect dimension for a total acqui-
sition time of 2.5 h. Each NMR sample consists of 100
lM protein and 400 lM compound in a Bis-Tris buffer
in 95% H2O, 5% D2O at pH 7.0 (uncorrected). The
spectra were processed using NMRPipe94 on a Intel
Xeon 3.06 GHz dual processor Linux Workstation.
Chemical shift differences were identified by compar-
ing a reference 2D 1H-15N HSQC spectrum of the free
protein to the spectrum of the compound-protein sam-
ples. CSPs were then mapped onto the surface of the
PA1324 structure (PDB ID: 1XPN) and visualized using
VMD-XPLOR.95 Only one compound, suramin, exhibited
a definitive binding site. A series of titration experiments
were done with increasing amount of suramin to deter-
mine the binding site. The PA1324 concentration was
approximately constant at 100 lM in a single tube
whereas the suramin concentrations were increased
from 0 to 5 lM, 10 lM, 15 lM, 20 lM, 25 lM, 50 lM,
100 lM, 200 lM, 300 lM, 400 lM, 500 lM, and 600
lM. A titration experiment was also done with a hetero-
geneous sample of heparin (Sigma Aldrich, St. Louis,
MO) to verify suramin binding to PA1324 was analogous
to PA1324 binding heparin. Because the heterogeneous
heparin sample has a molecular weight range of 6–12
kDa, an average MW of 9 kDa was used for determining
the heparin concentration for the titration experiment.
The PA1324 was again held constant at 100 lM whereas
the heparin concentrations were increased from 0 to 5
lM, 10 lM, 15 lM, 20 lM, 25 lM, and 50 lM. At higher
heparin concentrations, PA1324 began to precipitate out
of solution. The addition of suramin and heparin caused
chemical shift changes and peak broadening, where
some peaks were broaden beyond detection at higher
ligand concentrations. KD were measured by fitting
chemical shift changes [D(ppm)] versus ligand concen-




The chemical shift changes were measured as:
DðppmÞ ¼ ðDNHÞ




where DNH is the difference between free and bound
1H amide chemical shifts (ppm) and D15N is the dif-
ference between free and bound 15N chemical shifts
(ppm). The chemical shift changes from the suramin
and heparin titrations for eleven and eight PA1324 res-
idues, respectively, were superimposed based on nor-
malizing the average chemical shift changes. A KD was
measured by simultaneously fitting a single binding
curve to this data using KaleidaGraph (Synergy Soft-
ware, Reading, PA). A KD of 152  18 lM with an R2
of 0.89 was determined for suramin binding to
PA1324 and a KD of 51  14 lM with an R2 of 0.84
was determined for heparin binding to PA1324 [Fig.
2(S)].
AutoDock96 was used to model the interaction
between suramin and PA1324. Amides found to
undergo CSPs following suramin binding were used to
define a binding site region encompassing all the per-
turbed residues. A grid was manually defined within
AutoDock to encompass the determined ligand-bind-
ing site by adjusting the x,y,z coordinates for the cen-
ter of the grid box to position the grid in the binding
pocket. The grid size is determined by the number of
points in the x,y,z dimensions and is just visibly large
enough to fit the entire ligand. The co-structures are
selected based on a consistency with the observed
CSPs in the 2D 1H-15N HSQC spectra.
CPASS database and software was developed to
aid in the functional annotation of hypothetical pro-
teins by using a protein-ligand co-structure.14 The
CPASS database contains 27,000 ligand-defined
active-sites identified from structures deposited in the
PDB. CPASS returns a similarity score (0–100%) and
an interactive 3D graphical display of the structural
alignment for each active-site comparison. The CPASS
software runs on 16-node Beowulf Linux cluster with a
simple web-based interface. Each comparison averages
40s requiring 18 h to complete a comparison
against the entire database.
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spectrum of free PA1324 (black) and PA1324 in the presence of heterogeneous heparin (red). A 25 M 
PA1324 sample was titrated with approximately 100 M of heparin. The chemical shift perturbations 




Fig. 2S: Suramin (A) and heparin (B) PA1324 titration curves. PA1324 chemical shift changes are plotted 
versus ligand concentration. Chemical shift changes for multiple residues are superimposed by 
normalizing to the average chemical shift changes, where eleven residues are used for the suramin 
titration and eight residues for the heparin titration. The solid line represents the best-fit to the Langmuir 
isotherm equation.  
(A)                           (B) 
